Guided Therapeutics (GTHP) Income towards Parent Company (2010 - 2026)
Guided Therapeutics (GTHP) posted Income towards Parent Company of -$1.2 million for Q4 2025, down 64.15% sequentially from -$742000.0 in Q3 2025, and down 86.81% YoY from -$9.2 million in Q4 2024.
Guided Therapeutics (GTHP) Income towards Parent Company (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Income towards Parent Company for 16 years, with the latest figure at -$1.2 million in Q4 2025.
- Quarterly Income towards Parent Company fell 86.81% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.2 million (down 32.31% YoY) and the FY2025 annual result came in at -$3.2 million, down 32.23% from the prior year.
- Income towards Parent Company fell to -$1.2 million in Q4 2025 per GTHP's latest filing, from -$742000.0 in the prior quarter.
- Over five years, Income towards Parent Company peaked at $68000.0 in Q3 2021 and troughed at -$1.8 million in Q4 2022.
- A 5-year average of -$768650.0 and a median of -$693000.0 in 2023 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2021 and 2022: Income towards Parent Company jumped 84.68% in 2021, then slumped 1720.59% in 2022.
- Over 5 years, Income towards Parent Company stood at -$444000.0 in 2021, then slumped by 306.98% to -$1.8 million in 2022, then jumped by 78.64% to -$386000.0 in 2023, then slumped by 68.91% to -$652000.0 in 2024, then plunged by 86.81% to -$1.2 million in 2025.
- According to Business Quant data, Income towards Parent Company over the past three periods registered -$1.2 million, -$742000.0, and -$811000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -605,000.00 |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -709,000.00 |
| Mar 31, 2024 | -402,000.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Jun 30, 2023 | -1.56 Mn |
| Mar 31, 2023 | -869,000.00 |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | -926,000.00 |
| Mar 31, 2022 | -507,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -1.03 Mn |